Poland's NFZ spent 187M PLN refunding Ozempic in 5 months — up 51%

Poland's National Health Fund (NFZ) spent nearly 186.8 million PLN refunding Ozempic between January and May this year — a 51% year-on-year increase. The drug is growing rapidly in popularity among Polish patients, according to data cited by Rynek Zdrowia.